Haemonetics Corp (HAE) Stock Price, Quote & News

Company Profile

Haemonetics Corporation, a medical technology company, provides a suite of hospital technologies solutions in the United States and internationally. The company offers automated plasma collection systems, donor management software, and supporting software solutions, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and solutions, as well as integrated information technology platforms for plasma customers to manage their donors, operations, and supply chain; and NexLy...

Industry: Medical Devices

Sector: Healthcare

Phone: 781 848 7100

Website: www.haemonetics.com

Address:

125 Summer Street, Boston, United States

Cutlass Apr. 24 at 3:21 PM

$HAE Patience - in time, in time 👀

0 · Reply

OfficialStocktwitsUser Apr. 8 at 8:57 PM

$HAE RSI: 50.04, MACD: -1.1586 Vol: 1.96, MA20: 57.97, MA50: 60.77 🟢 BUY - Uptrend + healthy RSI 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.

0 · Reply

Renecurtis Mar. 25 at 9:55 AM

$HAE almost there

0 · Reply

ZacksResearch Mar. 12 at 3:07 PM

$HAE down 7.7% compared to the industry's 17% decline — can the hospital business recovery save it? 📉 🏥 Strong Hospital recovery with Attune Medica and OpSens acquisitions 🔬 NexSys PCS system adoption driving margin expansion ⚠️ Watch out for debt concerns and competitive pressures Full analysis here 👉 https://www.zacks.com/stock/news/2883093/is-it-apt-to-retain-haemonetics-stock-in-your-portfolio-for-now?cid=sm-stocktwits-2-2883093-body-37153&ADID=SYND_STOCKTWITS_TWEET_2_2883093_BODY_37153

0 · Reply

ZacksResearch Mar. 12 at 2:07 PM

$HAE showing growth signals — but the risk side of the story isn’t going away. ⚠️ NexSys PCS adoption and hospital recovery point to potential growth ahead, yet a leveraged balance sheet and stiff competition continue to cloud the company’s outlook. See the full risk/reward breakdown 👉 https://www.zacks.com/stock/news/2883093/is-it-apt-to-retain-haemonetics-stock-in-your-portfolio-for-now?cid=sm-stocktwits-2-2883093-teaser-37151&ADID=SYND_STOCKTWITS_TWEET_2_2883093_TEASER_37151

0 · Reply

Cutlass Mar. 11 at 4:07 PM

$HAE Come on down !

0 · Reply

erevnon Mar. 11 at 3:59 PM

Citigroup maintains Haemonetics $HAE at Neutral and lowers the price target from $75 to https://marketsblock.com/stock-upgrades-and-downgrades/

0 · Reply

TechridyStocks Mar. 3 at 4:32 PM

$HAE very strong

0 · Reply

SuperGreenToday Mar. 3 at 2:40 PM

$HAE Share Price: $62.55 Contract Selected: Sep 18, 2026 $70 Calls Buy Zone: $8.25 – $10.20 Target Zone: $13.24 – $16.18 Potential Upside: 51% ROI Time to Expiration: 198 Days | Updates via https://fxcapta.com/stockinfo/

0 · Reply

Estimize Feb. 27 at 12:03 AM

Wall St is expecting 1.27 EPS for $HAE Q4 [Reporting 05/07 BMO] http://www.estimize.com/intro/hae?chart=historical&metric_name=eps&utm_cont

0 · Reply

New Study Highlights Safety and Efficacy Profile of Haemonetics' VASCADE MVP® XL in Large-Bore Venous Access Closure Procedures

Apr 1, 2026, 4:05 PM EDT - 25 days ago

Haemonetics Sets Date for Publishing Fourth Quarter and Fiscal Year 2026 Results: May 7, 2026

Mar 30, 2026, 4:15 PM EDT - 27 days ago

Haemonetics Receives FDA Approval for Expanded Labeling of the VASCADE MVP® XL Venous Vascular Closure System

Mar 2, 2026, 10:25 AM EST - 2 months ago

Haemonetics Transcript: 47th Annual Raymond James Institutional Investor Conference

Feb 23, 2026, 4:15 PM EST - 2 months ago

Haemonetics Receives FDA Clearance for NexSys® PCS Plasma Collection System with Persona® PLUS Technology

Feb 20, 2026, 4:05 PM EST - 2 months ago

Haemonetics to Present at Raymond James 47th Annual Institutional Investors Conference

Feb 6, 2026, 12:28 PM EST - 2 months ago

These Analysts Revise Their Forecasts On Haemonetics After Q3 Earnings

Feb 5, 2026, 8:00 AM EST - 2 months ago

Haemonetics Earnings Call Transcript: Q3 2026

Feb 5, 2026, 6:00 AM EST - 2 months ago

Haemonetics Corporation Announces Third Quarter Fiscal 2026 Financial Results Available on Investor Relations Website

Jan 13, 2026, 10:30 AM EST - 3 months ago

Haemonetics Transcript: 44th Annual J.P. Morgan Healthcare Conference

Jan 12, 2026, 9:00 AM EST - 3 months ago

Orchestra BioMed to Receive Up to $21 Million in Proceeds from Acquisition of Vivasure by Haemonetics

OBIO

Jan 9, 2026, 8:00 AM EST - 3 months ago

Vivasure Medical Announces Acquisition by Haemonetics Corporation

Jan 9, 2026, 6:15 AM EST - 3 months ago

Haemonetics Acquires Vivasure Medical Limited

Jan 7, 2026, 6:17 PM EST - 3 months ago

Haemonetics Sets Date for Publishing Third Quarter Fiscal Year 2026 Results: February 5, 2026

Jan 2, 2026, 6:00 AM EST - 4 months ago

Haemonetics to Present at 44th Annual J.P. Morgan Healthcare Conference

Dec 30, 2025, 12:50 PM EST - 4 months ago

Earn Twice The Yield You Get From Bank On HAE Stock

Dec 2, 2025, 9:01 AM EST - 5 months ago

Top 2 Health Care Stocks You May Want To Dump This Month

EXAS

Nov 6, 2025, 8:00 AM EST - 6 months ago

Haemonetics Earnings Call Transcript: Q2 2026

Nov 6, 2025, 6:00 AM EST - 6 months ago

Haemonetics Corporation Announces Second Quarter Fiscal 2026 Financial Results Available on Investor Relations Website

Oct 9, 2025, 4:05 PM EDT - 7 months ago

Haemonetics Sets Date for Publishing Second Quarter Fiscal Year 2026 Results: November 6, 2025

Aug 8, 2025, 9:14 AM EDT - 9 months ago

These Analysts Slash Their Forecasts On Haemonetics After Q1 Results

Aug 7, 2025, 8:00 AM EDT - 9 months ago

Haemonetics Earnings Call Transcript: Q1 2026

Aug 7, 2025, 6:00 AM EDT - 9 months ago

Haemonetics 1st Quarter Fiscal Year 2026 Earnings Release Available on Investor Relations Website

Jul 9, 2025, 4:05 PM EDT - 10 months ago

Haemonetics Sets Date for Publishing First Quarter Fiscal Year 2026 Results: August 7, 2025

Jun 9, 2025, 8:40 AM EDT - 11 months ago

Haemonetics Transcript: Goldman Sachs 46th Annual Global Healthcare Conference

May 30, 2025, 6:00 AM EDT - 11 months ago

Haemonetics to Present at Goldman Sachs 46th Annual Global Healthcare Conference

May 8, 2025, 8:00 AM EDT - 1 year ago

Haemonetics Earnings Call Transcript: Q4 2025

May 8, 2025, 6:00 AM EDT - 1 year ago

Haemonetics 4th Quarter and Fiscal Year 2025 Earnings Release Available on Investor Relations Website

Mar 31, 2025, 4:00 PM EDT - 1 year ago

Haemonetics Sets Date for Publishing Fourth Quarter and Fiscal Year 2025 Results: May 8, 2025

Mar 4, 2025, 2:50 PM EST - 1 year ago

Haemonetics Transcript: Raymond James & Associates’ 46th Annual Institutional Investors Conference 2025

Mar 3, 2025, 4:10 PM EST - 1 year ago

Haemonetics Announces Executive Leadership Updates

Feb 24, 2025, 6:00 AM EST - 1 year ago

Haemonetics to Present at Raymond James 46th Annual Institutional Investors Conference

Feb 6, 2025, 8:00 AM EST - 1 year ago

Haemonetics Earnings Call Transcript: Q3 2025

Feb 6, 2025, 6:00 AM EST - 1 year ago

Haemonetics 3rd Quarter Fiscal Year 2025 Earnings Release Available on Investor Relations Website

Jan 14, 2025, 8:15 PM EST - 1 year ago

Haemonetics Transcript: 43rd Annual J.P. Morgan Healthcare Conference 2025

Jan 14, 2025, 6:13 AM EST - 1 year ago

Haemonetics Completes Sale of Whole Blood Assets to GVS, S.p.A

Jan 8, 2025, 5:03 PM EST - 1 year ago

Haemonetics Sets Date for Publishing Third Quarter Fiscal Year 2025 Results: February 6, 2025

Jan 6, 2025, 6:00 AM EST - 1 year ago

Haemonetics to Present at 43rd Annual J.P. Morgan Healthcare Conference

Dec 3, 2024, 1:16 AM EST - 1 year ago

Haemonetics Announces Sale of Whole Blood Assets to GVS, S.p.A

Nov 7, 2024, 8:00 AM EST - 1 year ago

Haemonetics Earnings Call Transcript: Q2 2025

Nov 7, 2024, 6:00 AM EST - 1 year ago

Haemonetics 2nd Quarter Fiscal Year 2025 Earnings Release Available on Investor Relations Website

Oct 3, 2024, 4:05 PM EDT - 1 year ago

Haemonetics Sets Date for Publishing Second Quarter Fiscal Year 2025 Results: November 7, 2024

Aug 16, 2024, 7:57 AM EDT - 1 year ago

Top 3 Health Care Stocks That Are Set To Fly This Quarter

IBRX PGNY

Aug 15, 2024, 6:30 AM EDT - 1 year ago

Haemonetics Announces Full Market Release for VASCADE MVP® XL Vascular Closure System

Aug 8, 2024, 8:00 AM EDT - 1 year ago

Haemonetics Earnings Call Transcript: Q1 2025

Aug 8, 2024, 6:00 AM EDT - 1 year ago

Haemonetics 1st Quarter Fiscal Year 2025 Earnings Release Available on Investor Relations Website

Jul 30, 2024, 6:00 AM EDT - 1 year ago

Haemonetics Announces CE Mark Certification for the SavvyWire® Pre-Shaped Pressure Guidewire

Jul 8, 2024, 4:05 PM EDT - 1 year ago

Haemonetics Sets Date for Publishing First Quarter Fiscal Year 2025 Results: August 8, 2024

Jun 18, 2024, 4:15 PM EDT - 2 years ago

Haemonetics Launches Limited Market Release for New VASCADE MVP XL Vascular Closure Device

May 23, 2024, 6:00 AM EDT - 2 years ago

Haemonetics Prices Upsized Private Placement of $600 Million Convertible Senior Notes

May 21, 2024, 4:05 PM EDT - 2 years ago

Haemonetics Announces Proposed Convertible Senior Notes Offering

May 9, 2024, 8:00 AM EDT - 2 years ago

Haemonetics Earnings Call Transcript: Q4 2024

May 9, 2024, 6:00 AM EDT - 2 years ago

Haemonetics 4th Quarter and Fiscal Year 2024 Earnings Release Available on Investor Relations Website

Apr 10, 2024, 4:58 PM EDT - 2 years ago

Haemonetics Sets Date for Publishing Fourth Quarter and Fiscal Year 2024 Results: May 9, 2024

Apr 4, 2024, 6:30 AM EDT - 2 years ago

Haemonetics Receives FDA Clearance for New TEG® 6s Global Hemostasis - HN Cartridge

Apr 1, 2024, 8:00 AM EDT - 2 years ago

Haemonetics Corporation Completes Acquisition of Attune Medical

Mar 5, 2024, 7:30 AM EST - 2 years ago

Haemonetics Transcript: 45th Annual Raymond James Institutional Investors Conference 2024

Mar 5, 2024, 6:00 AM EST - 2 years ago

Haemonetics Announces Definitive Agreement to Acquire Attune Medical

Feb 21, 2024, 5:57 PM EST - 2 years ago

Haemonetics to Present at Raymond James 45th Annual Institutional Investors Conference

Feb 21, 2024, 5:55 PM EST - 2 years ago

Haemonetics to Present at Citi's 2024 Unplugged Medtech and Life Sciences Access Day

Feb 8, 2024, 8:00 AM EST - 2 years ago

Haemonetics Earnings Call Transcript: Q3 2024

Feb 8, 2024, 6:00 AM EST - 2 years ago

Haemonetics 3rd Quarter Fiscal Year 2024 Earnings Release Available on Investor Relations Website

Jan 11, 2024, 4:05 PM EST - 2 years ago

Haemonetics Sets Date for Publishing Third Quarter Fiscal Year 2024 Results: February 8, 2024

Jan 9, 2024, 12:45 PM EST - 2 years ago

Haemonetics Transcript: J.P. Morgan 2024 42nd Annual Healthcare Conference

Dec 12, 2023, 6:00 AM EST - 2 years ago

Haemonetics Corporation Completes Acquisition of OpSens Inc.

Dec 7, 2023, 4:05 PM EST - 2 years ago

Haemonetics to Present at 42nd Annual J.P. Morgan Healthcare Conference

Nov 2, 2023, 8:00 AM EDT - 2 years ago

Haemonetics Earnings Call Transcript: Q2 2024

Aug 8, 2023, 8:00 AM EDT - 2 years ago

Haemonetics Earnings Call Transcript: Q1 2024

May 11, 2023, 8:00 AM EDT - 3 years ago

Haemonetics Earnings Call Transcript: Q4 2023

Feb 7, 2023, 8:00 AM EST - 3 years ago

Haemonetics Earnings Call Transcript: Q3 2023

Jan 10, 2023, 5:15 PM EST - 3 years ago

Haemonetics Transcript: JPMorgan Healthcare Conference

Nov 7, 2022, 10:00 AM EST - 3 years ago

Haemonetics Earnings Call Transcript: Q2 2023

Sep 12, 2022, 8:45 AM EDT - 3 years ago

Haemonetics Transcript: Morgan Stanley 20th Annual Global Healthcare Conference

Aug 10, 2022, 8:00 AM EDT - 4 years ago

Haemonetics Earnings Call Transcript: Q1 2023

Jun 28, 2022, 8:13 PM EDT - 4 years ago

Haemonetics Transcript: Investor Day 2022

May 10, 2022, 5:50 AM EDT - 4 years ago

Haemonetics Earnings Call Transcript: Q4 2022

Feb 8, 2022, 4:32 AM EST - 4 years ago

Haemonetics Earnings Call Transcript: Q3 2022

Nov 8, 2021, 7:00 PM EST - 4 years ago

Haemonetics Earnings Call Transcript: Q2 2022

Aug 10, 2021, 8:00 PM EDT - 5 years ago

Haemonetics Earnings Call Transcript: Q1 2022

May 13, 2021, 7:21 AM EDT - 5 years ago

Haemonetics Earnings Call Transcript: Q4 2021

Feb 2, 2021, 8:00 AM EST - 5 years ago

Haemonetics Earnings Call Transcript: Q3 2021

Jan 20, 2021, 8:00 AM EST - 5 years ago

Haemonetics Transcript: M&A Announcement

Nov 4, 2020, 8:00 AM EST - 5 years ago

Haemonetics Earnings Call Transcript: Q2 2021

Aug 4, 2020, 8:00 AM EDT - 6 years ago

Haemonetics Earnings Call Transcript: Q1 2021

May 5, 2020, 8:00 AM EDT - 6 years ago

Haemonetics Earnings Call Transcript: Q4 2020

Feb 4, 2020, 8:00 AM EST - 6 years ago

Haemonetics Earnings Call Transcript: Q3 2020

Nov 1, 2019, 8:00 AM EDT - 7 years ago

Haemonetics Earnings Call Transcript: Q2 2020

Aug 6, 2019, 8:00 AM EDT - 7 years ago

Haemonetics Earnings Call Transcript: Q1 2020

May 7, 2019, 8:00 AM EDT - 7 years ago

Haemonetics Earnings Call Transcript: Q4 2019

Feb 5, 2019, 8:00 AM EST - 7 years ago

Haemonetics Earnings Call Transcript: Q3 2019

Nov 6, 2018, 8:00 AM EST - 8 years ago

Haemonetics Earnings Call Transcript: Q2 2019

Aug 7, 2018, 8:00 AM EDT - 8 years ago

Haemonetics Earnings Call Transcript: Q1 2019

May 8, 2018, 8:00 AM EDT - 8 years ago

Haemonetics Earnings Call Transcript: Q4 2018

Feb 6, 2018, 8:00 AM EST - 8 years ago

Haemonetics Earnings Call Transcript: Q3 2018

Nov 7, 2017, 8:00 AM EST - 9 years ago

Haemonetics Earnings Call Transcript: Q2 2018

Aug 7, 2017, 8:00 AM EDT - 9 years ago

Haemonetics Earnings Call Transcript: Q1 2018

Jun 19, 2017, 11:00 AM EDT - 9 years ago

Haemonetics Transcript: Investor Day 2017

May 8, 2017, 8:00 AM EDT - 9 years ago

Haemonetics Earnings Call Transcript: Q4 2017

Feb 6, 2017, 8:00 AM EST - 10 years ago

Haemonetics Earnings Call Transcript: Q3 2017

Nov 7, 2016, 8:00 AM EST - 10 years ago

Haemonetics Earnings Call Transcript: Q2 2017

Aug 1, 2016, 8:00 AM EDT - 10 years ago

Haemonetics Earnings Call Transcript: Q1 2017

May 10, 2016, 9:30 AM EDT - 10 years ago

Haemonetics Transcript: Investor Day 2016

May 2, 2016, 8:00 AM EDT - 10 years ago

Haemonetics Earnings Call Transcript: Q4 2016

Feb 1, 2016, 8:00 AM EST - 11 years ago

Haemonetics Earnings Call Transcript: Q3 2016

Nov 4, 2015, 8:00 AM EST - 11 years ago

Haemonetics Earnings Call Transcript: Q2 2016

Jul 27, 2015, 8:00 AM EDT - 11 years ago

Haemonetics Earnings Call Transcript: Q1 2016

Cutlass Apr. 24 at 3:21 PM

$HAE Patience - in time, in time 👀

0 · Reply

OfficialStocktwitsUser Apr. 8 at 8:57 PM

0 · Reply

Renecurtis Mar. 25 at 9:55 AM

$HAE almost there

0 · Reply

ZacksResearch Mar. 12 at 3:07 PM

0 · Reply

ZacksResearch Mar. 12 at 2:07 PM

0 · Reply

Cutlass Mar. 11 at 4:07 PM

$HAE Come on down !

0 · Reply

erevnon Mar. 11 at 3:59 PM

Citigroup maintains Haemonetics $HAE at Neutral and lowers the price target from $75 to https://marketsblock.com/stock-upgrades-and-downgrades/

0 · Reply

TechridyStocks Mar. 3 at 4:32 PM

$HAE very strong

0 · Reply

SuperGreenToday Mar. 3 at 2:40 PM

0 · Reply

Estimize Feb. 27 at 12:03 AM

Wall St is expecting 1.27 EPS for $HAE Q4 [Reporting 05/07 BMO] http://www.estimize.com/intro/hae?chart=historical&metric_name=eps&utm_cont

0 · Reply

OpenOutcrier Feb. 24 at 2:05 PM

$HAE (+2.0% pre) New Haemonetics tech helps plasma centers collect more per donor https://ooc.bz/l/94447

0 · Reply

ClassiTrader Feb. 23 at 9:42 PM

$HAE $HAEMONETICS Corp Mass Receives FDA Clearance for NexSys® PCS Plasma Collection System with Persona® PLUS Technology

0 · Reply

alshamiak Feb. 22 at 3:22 PM

$HAE #SWING

0 · Reply

dred48 Feb. 18 at 3:20 PM

$HAE switch turned on again

0 · Reply

Renecurtis Feb. 9 at 4:27 PM

$HAE waiting for that 51$ to enter here

0 · Reply

Cutlass Feb. 6 at 3:44 PM

$HAE Load Zone 44 - 52 ✍️ Gap Nov 5 at 51.72 👀

0 · Reply

ZacksResearch Feb. 6 at 3:14 PM

$HAE beats estimates but shares drop — what’s going on? 📉 EPS of $1.31 topped estimates by 3.1%, while Q3 revenues surpassed consensus by 1.4%. Yet, shares fell 1.4% due to concerns over a 2.7% quarterly revenue decline. Full breakdown here 👉 https://www.zacks.com/stock/news/2836313/haemonetics-q3-earnings-revenues-beat-margins-up-stock-slips?cid=sm-stocktwits-2-2836313-body-32307&ADID=SYND_STOCKTWITS_TWEET_2_2836313_BODY_32307

0 · Reply

ZacksResearch Feb. 6 at 2:14 PM

Earnings beat… and the stock drops? $HAE sends mixed signals. ⚠️ Q3 EPS and revenues beat estimates with sharply higher margins, but sales fell 2.7% year over year — enough to push shares lower after the report. See what the market is focusing on 👉 https://www.zacks.com/stock/news/2836313/haemonetics-q3-earnings-revenues-beat-margins-up-stock-slips?cid=sm-stocktwits-2-2836313-teaser-32306&ADID=SYND_STOCKTWITS_TWEET_2_2836313_TEASER_32306

0 · Reply

erevnon Feb. 6 at 1:44 PM

Barrington Research maintains Haemonetics $HAE at Outperform and raises the price target from $93 to https://marketsblock.com/stock-upgrades-and-downgrades/

0 · Reply

StocktwitsEarnings Feb. 5 at 11:13 AM

$HAE Q3 '26 Earnings Results & Recap • Reported GAAP EPS of $0.96 up 28.00% YoY • Reported revenue of $338.97M down -2.75% YoY

0 · Reply

OracleObelisk Feb. 4 at 9:31 AM

$HAE medical devices, plasma and blood management

0 · Reply

OfficialStocktwitsUser Feb. 4 at 2:01 AM

$HAE RSI: 4.62, MACD: -3.6222 Vol: 6.83, MA20: 73.00, MA50: 77.93 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.

0 · Reply

Market Cap	2.79B
Revenue (ttm)	1.36B
Net Income (ttm)	167.68M
EPS (ttm)	N/A
PE Ratio	12.12
Forward PE	11.29
Profit Margin	12.32%
Debt to Equity Ratio	1.01

Volume	262,636
Avg Vol	744,322
Day's Range	N/A - N/A
Shares Out	46.47M
Stochastic %K	37%
Beta	0.36
Analysts	Strong Sell
Price Target	$85.10